CA1049406A - Isolation of hemagglutinin and neuraminidase from influenza virus - Google Patents

Isolation of hemagglutinin and neuraminidase from influenza virus

Info

Publication number
CA1049406A
CA1049406A CA217,790A CA217790A CA1049406A CA 1049406 A CA1049406 A CA 1049406A CA 217790 A CA217790 A CA 217790A CA 1049406 A CA1049406 A CA 1049406A
Authority
CA
Canada
Prior art keywords
chloride
bromide
virus
cationic detergent
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA217,790A
Other languages
English (en)
French (fr)
Other versions
CA217790S (en
Inventor
Helmut Bachmayer
Gerhard Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1049406A publication Critical patent/CA1049406A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
CA217,790A 1974-01-14 1975-01-13 Isolation of hemagglutinin and neuraminidase from influenza virus Expired CA1049406A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (forum.php) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
CA1049406A true CA1049406A (en) 1979-02-27

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
CA217,790A Expired CA1049406A (en) 1974-01-14 1975-01-13 Isolation of hemagglutinin and neuraminidase from influenza virus

Country Status (27)

Country Link
JP (2) JPS58407B2 (forum.php)
AT (1) AT345449B (forum.php)
AU (1) AU500250B2 (forum.php)
BE (1) BE824372A (forum.php)
CA (1) CA1049406A (forum.php)
CH (1) CH589453A5 (forum.php)
CS (1) CS191254B2 (forum.php)
DD (1) DD116239A5 (forum.php)
DE (1) DE2500785B2 (forum.php)
DK (1) DK140003B (forum.php)
ES (1) ES433759A1 (forum.php)
FI (1) FI54053C (forum.php)
FR (1) FR2257305B1 (forum.php)
GB (1) GB1498261A (forum.php)
HK (1) HK56380A (forum.php)
HU (1) HU173920B (forum.php)
IE (1) IE40794B1 (forum.php)
IL (1) IL46426A (forum.php)
MY (1) MY8100204A (forum.php)
NL (1) NL166622C (forum.php)
NO (1) NO143128C (forum.php)
PH (1) PH14458A (forum.php)
PL (1) PL93689B1 (forum.php)
SE (1) SE427238B (forum.php)
SU (1) SU616997A3 (forum.php)
YU (1) YU41289B (forum.php)
ZA (1) ZA75259B (forum.php)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
PL1951296T5 (pl) * 2005-11-01 2015-06-30 Seqirus Uk Ltd Szczepionki wirusowe otrzymane z komórek o niskim poziomie pozostałości DNA komórkowego poprzez traktowanie beta-propiolaktonem
HRP20140375T1 (hr) * 2007-08-28 2014-06-20 Baxter International Inc. Postupak za proizvodnju virusnih cjepiva
KR20160068972A (ko) 2013-11-15 2016-06-15 노파르티스 아게 잔여 세포 배양 불순물의 제거

Also Published As

Publication number Publication date
SU616997A3 (ru) 1978-07-25
HU173920B (hu) 1979-09-28
JPS56127319A (en) 1981-10-06
DE2500785C3 (forum.php) 1980-09-11
IL46426A0 (en) 1975-04-25
PL93689B1 (forum.php) 1977-06-30
FR2257305A1 (forum.php) 1975-08-08
AU500250B2 (en) 1979-05-17
YU5875A (en) 1984-04-30
FR2257305B1 (forum.php) 1982-03-19
NL166622B (nl) 1981-04-15
DK1475A (forum.php) 1975-09-01
JPS50100224A (forum.php) 1975-08-08
CS191254B2 (en) 1979-06-29
ES433759A1 (es) 1977-02-16
IE40794L (en) 1975-07-14
AU7730575A (en) 1976-07-15
MY8100204A (en) 1981-12-31
GB1498261A (en) 1978-01-18
DD116239A5 (forum.php) 1975-11-12
JPS6035326B2 (ja) 1985-08-14
AT345449B (de) 1978-09-11
SE7500130L (forum.php) 1975-07-15
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
ATA21475A (de) 1978-01-15
DE2500785B2 (de) 1980-01-03
SE427238B (sv) 1983-03-21
DK140003B (da) 1979-06-05
JPS58407B2 (ja) 1983-01-06
CH589453A5 (forum.php) 1977-07-15
YU41289B (en) 1987-02-28
FI54053C (fi) 1978-10-10
NL166622C (nl) 1981-09-15
BE824372A (fr) 1975-07-14
NO143128B (no) 1980-09-15
PH14458A (en) 1981-07-29
NL7500301A (nl) 1975-07-16
DE2500785A1 (de) 1975-07-31
IE40794B1 (en) 1979-08-15
NO750031L (forum.php) 1975-08-11
FI750014A7 (forum.php) 1975-07-15
FI54053B (fi) 1978-06-30
HK56380A (en) 1980-10-16
IL46426A (en) 1978-01-31
DK140003C (forum.php) 1979-10-29

Similar Documents

Publication Publication Date Title
Guzman et al. An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV
US3962421A (en) Method for the disruption of lipid-containing viruses
US4064232A (en) Process for isolating the immunogenic components of influenza viruses
Leist et al. Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells.
CA1049406A (en) Isolation of hemagglutinin and neuraminidase from influenza virus
US4140762A (en) Influenza sub-unit vaccine
Rytel et al. The Influence of Cortisone on Experimental Viral Infection: VIII. Suppression by Cortisone of Interferon Formation in Mice Injected With Newcastle Disease Virus
AU2025205386A1 (en) Feline calicivirus vaccine
McLaren et al. Defective interfering particles from poliovirus vaccine and vaccine reference strains
AU2022209359A1 (en) Multivalent feline vaccine
JPH10508485A (ja) 弱毒化イヌパルボウイルス
Hooks et al. Isolation of a new simian foamy virus from a spider monkey brain culture
Alexandrova et al. Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates
US3892627A (en) Feline panleukopenia vaccine
CN103228293A (zh) 用于在哺乳动物中预防和治疗金迪普拉病毒感染的疫苗制剂
DE2829089A1 (de) Subunit-vakzine
US4946676A (en) Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide
Iwasaki et al. Communications: Effect of Lymphocytosis-Promoting Factor (LPF) on the Appearance of Antibodies in Mice Infected with Influenza Virus
CA1270438A (en) Influenza vaccine
KR790001144B1 (ko) 인플루엔자 백신의 제조방법
CA2112225C (en) Attenuated revertant serotype 1 marek's disease vaccine
EP3706789A1 (en) Feline calicivirus vaccine
Arai et al. Demonstration of non-infections hemagglutinating particles of rabies virus and isolation of the hemagglutinin by disruption of the virion with Nonidet P-40
Lomniczi Properties of non-neurovirulent plaque-forming mutants of Newcastle disease virus
Norrby Characteristics of the progeny derived from multiplication of Sendai virus in a measles virus carrier cell line